N-[4-[[6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]benzamide, 98%

Name: N-[4-[[6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]benzamide, 98% | 331771-20-1
Brand: J&K Chemical
SKU: JK832253_5_MG
Price: 55.6 USD
Availability: OutOfStock

Cat. No JK832253_5_MG

Vendor: J&K Chemical

Product Information

Product Name

N-4-6-Methoxy-7-3-(4-morpholinyl)propoxy-4-quinazolinylaminophenylbenzamide, 98%

Brand Name

J&K

Product Number

832253

CAS

331771-20-1

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

9914412

IUPAC Name

N-4-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-ylaminophenylbenzamide

InChI Key

OGNYUTNQZVRGMN-UHFFFAOYSA-N

SMILES

COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5

Safety Information

Storage Condition

Freezer -20℃

References Data Source From Pubchem

Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells

Publication Name: European Journal of Medicinal Chemistry

Publication Date: 2024-03-15

DOI: 10.1016/j.ejmech.2024.116255

Design, synthesis, and evaluation of dual EGFR/AURKB inhibitors as anticancer agents for non-small cell lung cancer

Publication Name: Bioorganic & Medicinal Chemistry Letters

Publication Date: 2024-03-01

DOI: 10.1016/j.bmcl.2024.129612

Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors

Publication Name: Bioorganic & Medicinal Chemistry

Publication Date: 2024-01-15

DOI: 10.1016/j.bmc.2023.117561

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma

Publication Name: Cancer Letters

Publication Date: 2023-08-01

DOI: 10.1016/j.canlet.2023.216284

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Publication Name: Science Translational Medicine

Publication Date: 2023-06-21

DOI: 10.1126/scitranslmed.add7872